UCBJF:OTCMKTS
UCB SA
240,24 USD
arrow_upward
+1,82%(+4,30) 1D
15-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCBJF...
Open
240,24 USD
High
240,24 USD
Low
240,24 USD
Mkt. cap
39,62 млд
Avg. vol.
139,00
Volume
10,00
52-wk high
345,39 USD
52-wk low
219,60 USD
Beta
0,58
Shares outstanding
194,51 млн
No. of employees
9 миң
Open
240,24 USD
High
240,24 USD
Low
240,24 USD
Mkt. cap
39,62 млд
Avg. vol.
139,00
Volume
10,00
52-wk high
345,39 USD
52-wk low
219,60 USD
Beta
0,58
Shares outstanding
194,51 млн
No. of employees
9 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
23 саат мурун
UCB dedicates Georgia campus as UCB stock sits 29.15 percent below its high
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9 миң
Founded1928-ж., 18-янв.
Headquarters-
SectorPharmaceutical industry
Websiteucb.com